Changes in cannabinoid CB1 receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis

Synapse

Volumn 41, Issue 3, 2001, Pages 195-202

  Berrendero, Fernando ^a   Sánchez, Antonio ^b   Cabranes, Ana ^a   Puerta, Carmen ^b   Ramos, José A ^a   García Merino, Antonio ^b   Fernández Ruiz, Javier ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Brain regions; Cannabinoids; CB1 receptors; EAE; Multiple sclerosis

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CAUDATE NUCLEUS; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; MOTOR ACTIVITY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; CANNABINOIDS; CEREBRAL CORTEX; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MALE; MORPHOLINES; MULTIPLE SCLEROSIS; NAPHTHALENES; PROTEIN BINDING; RATS; RATS, INBRED LEW; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER; SULFUR RADIOISOTOPES;

EID: 0035452419     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.1075     Document Type: Article

References (44)

1. Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: Implications for the treatment of acute relapses of multiple sclerosis
2. Cannabinoids control spasticity and tremor in a multiple sclerosis model
3. Endocannabinoids control spasticity in experimental multiple sclerosis
4. Functional role of high-affinity anandamide transport, as revealed by selective inhibition
5. Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development
6. Regional differences in cannabinoid receptor/G-protein coupling in rat brain
7. Tetrahydrocannabinol for tremor in multiple sclerosis
8. Brain cannabinoid systems as targets for the therapy of neurological disorders
9. The perceived effects of smoked cannabis on patient with multiple sclerosis
10. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
11. Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action
12. The endogenous cannabinoid system and brain development
13. Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM374)
14. A receptor alterations in the human basal ganglia in Huntington's disease
15. Short-term effects of smoking marihuana on balance in patients with multiple sclerosis and normal volunteers
16. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor
17. Characterization of cannabinoid receptors coupled to vasorelaxation by endothelium-derived hyperpolarizing factor
18. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
19. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
20. Pharmacology of cannabinoid receptors
21. 9-tetrahydrocannabinol: A novel treatment for experimental autoimmune encephalomyelitis
22. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
23. Immunological aspects of experimenttal allergic encephalomyelitis and multiple sclerosis
24. Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: Sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase
25. Nabilone in the treatment of multiple sclerosis
26. Identification of an endogenous 2-monogliceride, present in canine gut, that binds to cannabinoid receptors
27. Presence and functional regulation of cannabinoid receptors in immune cells
28. 2 receptors
29. Cannabinoid receptor ligands: Clinical and neuropharmacological considerations, relevant to future drug discovery and development
30. The endocannabinoid system as a target for therapeutic drugs
31. Drug treatment of multiple sclerosis
32. Aminoguanidine reduces apoptosis of circulating Vβ8.2T lymphocytes in Lewis rats with actively induced experimental autoimmune encephalomyelitis. Association with persistent inflammation of the central nervous system and lack of recovery
33. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function
34. Atypical location of cannabinoid receptors in white matter areas during rat brain development
35. The activation of cannabinoid receptors in striatonigral neurons inhibited GABA uptake
36. 1 receptor mRNA levels in the caudate-putamen
37. Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: An in situ hybridization study
38. 35S]-GTPγS autoradiography in rat brain
39. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
40. 9-THC in the treatment of spasticity associated with multiple sclerosis
41. Cardiovascular actions of cannabinoids and their generation during shock
42. Suppression of experimental autoimmune encephalomyelitis by cannabinoids